Ralph Kern work email
- Valid
- Valid
- Valid
Ralph Kern personal email
- Valid
Ralph Kern phone numbers
BIOPHARMACEUTICAL EXECUTIVE WITH BROAD VISION FOR CHANGEDriving transformation in patient care, drug and medical device discovery, and health care delivery.Ralph Kern is a people-centered executive and forward-looking change agent with a commitment to translating science into optimal patient outcomes—and to changing health care systems to accommodate biopharmaceutical and medical device innovation.Dr. Kern’s decades-long career includes experience in academic medicine and biotechnology.In his current role as Chief Medical Officer at Cognito Therapeutics he drives innovation and finds solutions for neurodegenerative diseases including Alzheimer’s Disease, multiple sclerosis and Parkinson’s Disease.Dr. Kern cares deeply about people. For this reason, he has focused his attention, and his career, on medical innovation, ensuring that patients receive the therapies they need through scientific advancement and changing health care systems for the better.
-
Chief Medical OfficerCognito Therapeutics, Inc. Mar 2023 - PresentCambridge, Ma, Us
-
President And Chief Medical OfficerBrainstorm Cell Therapeutics Apr 2020 - Feb 2023Kiryat Aryeh, Petach Tikva, Il -
Evp, Chief Operating OfficerBrainstorm Cell Therapeutics Mar 2017 - Apr 2020Kiryat Aryeh, Petach Tikva, Il
-
Svp, Head Worldwide MedicalBiogen Mar 2016 - Feb 2017Cambridge, Ma, UsEstablished and currently oversee all therapeutic areas, corporate medical governance, regional medical activities, and global medical operations within Biogen’s Worldwide Medical organization. Provide organizational leadership and team building for global teams. Define medical and scientific strategies for Alzheimer’s disease, MS, spinal muscular atrophy, Parkinson’s, neurodegeneration, and hemophilia. -
Vp, Head Global Therapeutic AreasBiogen Aug 2015 - Mar 2016Cambridge, Ma, UsDeveloped strategies for global therapeutic areas while building a well-aligned, efficient, and forward-moving organization. Directed medical launch activities, key opinion leader (KOL) engagement strategies, and data generation. Participated in formulating Biogen’s global governance policies as well as medical and scientific elements of the company’s competitive strategy.
-
Vp, Head Global Medical NeurologyBiogen Apr 2015 - Aug 2015Cambridge, Ma, UsOversaw strategy for MS, Alzheimer’s disease, and provided early-pipeline support for neurodegenerative diseases and spinal muscular atrophy. Mobilized teams to simplify medical communications and leverage technology platforms to reach health care providers in support of patients worldwide.
-
Vp, Head Neuroscience Medical UnitNovartis Oct 2014 - Mar 2015Basel, Baselstadt, ChProvided strategic and hands-on leadership for MS and Neuroscience Medical Units. Directed health care operations and innovation, managed budgets, and motivated teams. Served as core member of the U.S. Medical Leadership Team, U.S. Product & Development Alignment Board, and Neuroscience Franchise Leadership Team. -
Vp, Head Ms Medical UnitNovartis Jan 2011 - Sep 2014Basel, Baselstadt, ChExecuted medical and strategic plans and drove life cycle management activities for Gilenya®, the first approved oral therapy in MS. Increased organizational impact and effectiveness by directing the Transforming Medical Capabilities initiative, designing the medical affairs customer engagement model, and doubling the size of the U.S. field medical team.
-
Global Medical Director, Personalized Genetic HealthSanofi Genzyme Sep 2010 - Dec 2010Paris, France, FrGuided global medical affairs, R&D, and medical-scientific activities for Fabry disease life cycle management. Directed the investigator-initiated research portfolio, consisting of global genetic and metabolomic / proteomic biomarker projects. -
General Manager, Fabry DiseaseSanofi Genzyme Jun 2008 - Oct 2010Paris, France, FrOversaw global commercial operations supporting patients with Fabry disease. Built relationships with key opinion leaders, directed product and business development, and represented the biologics franchise at Senior Management Committee and Quarterly Business Review meetings. Executed medical, regulatory, and stakeholder strategies to mitigate a prolonged supply disruption and provide life-sustaining medication to 2,600 patients in 52 markets worldwide.
-
Head Medical AffairsSanofi Genzyme 2006 - 2008Paris, France, FrProvided medical and scientific oversight for all marketed therapeutic products. Headed medical and scientific activities nationwide including sales force education, safety, and clinical research. Created the compliance framework and established the Medical Science Liaison function for rare genetic disorders.
-
Consultant NeurologistUniversity Health Network Jan 2001 - Oct 2006Toronto, Ontario, CaBalanced patient care with health care management in laboratory and clinic settings. Directed a prospective cohort study of postpartum headache, and led teams to identify and publish the first scientific description of central nervous system complication of the West Nile Virus epidemic in 2003. -
Head University Academic Neurology ProgramUniversity Of Toronto Jul 2003 - Jul 2006Toronto, Ontario, CaDefined training requirements for students and faculty, and developed problem-based curriculum for postgraduate education in neurology and neurology bioethics. Managed program operations and administration. Contributed to successful Royal College University of Toronto Neurology accreditation in 2006. -
Chief Division Of NeurologyCredit Valley Hospital 1988 - 2000Mississauga, Ontario, CaProvided organizational and divisional leadership while facilitating principal-investigator clinical trials for headache, epilepsy, and stroke. Served on the Executive Committee for the Department of Medicine.
Ralph Kern Skills
Ralph Kern Education Details
-
Dalla Lana School Of Public Health, University Of TorontoMasters Of Health Administration -
University Of TorontoPediatric Epilepsy
-
Mcgill UniversityNeurology Residency Program
-
University Of TorontoInternal Medicine Residency Program
-
Queen'S UniversityDoctor Of Medicine
-
Mcgill UniversityNeurophysiology
Frequently Asked Questions about Ralph Kern
What company does Ralph Kern work for?
Ralph Kern works for Cognito Therapeutics, Inc.
What is Ralph Kern's role at the current company?
Ralph Kern's current role is Neurologist/Chief Medical Officer.
What is Ralph Kern's email address?
Ralph Kern's email address is rk****@****ell.com
What is Ralph Kern's direct phone number?
Ralph Kern's direct phone number is +161791*****
What schools did Ralph Kern attend?
Ralph Kern attended Dalla Lana School Of Public Health, University Of Toronto, University Of Toronto, Mcgill University, University Of Toronto, Queen's University, Mcgill University.
What skills is Ralph Kern known for?
Ralph Kern has skills like Neurology, Pharmaceutical Industry, Clinical Research, Clinical Development, Biotechnology, Clinical Trials, Medicine, Neuroscience, Medical Affairs, Drug Development, Lifesciences, Market Access.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial